You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
SBC: ARISAPH PHARMACEUTICALS, INC. Topic: 102DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Brain penetrant Hsp90 inhibitors for Alzheimer's disease
SBC: YUMA THERAPEUTICS CORPORAITON Topic: NIADESCRIPTION provided by applicant Neurodegeneration in Alzheimerandapos s disease AD may result from deposition of A as plaques in brain tissue However less effort has been made to elucidate the role of tau containing neurofibrillary tangles NFTs in AD Accumulating evidence suggests that tau containing NFTs is an important component in the initiation and progression of AD and other neu ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Coils for Human Whole Body Imaging at 7T
SBC: LIFE SERVICES L.L.C. Topic: NIBIBDESCRIPTION provided by applicant For this Phase II STTR proposal the investigators plan to develop and commercialize the radiofrequency RF coil technology to make T body MRI possible and to translate this new technology to vastly improve T clinical MRI as well In the Phase I project leading to this proposal all specific aims were accomplished to demonstrate the feasibility of safely an ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Compact CMOS-Compatible Optical Transceiver
SBC: Physical Sciences Inc. Topic: AF14AT13ABSTRACT: Close integration of photonic devices with silicon complementary metal-oxide semiconductor (CMOS) electronics can yield significant performance improvements in many applications. The recent development of novel integrated structures in silicon including waveguides, resonators, and photodetectors will enable dramatic reductions in size, weight, and power for components implementing compl ...
STTR Phase I 2014 Department of DefenseAir Force -
Compact, low cost, wide band, high resolution integrated digital spectrometer on a chip
SBC: AGILTRON, INC. Topic: AF10BT39ABSTRACT: Leveraging Agiltron industry leading development and production of spectrometer systems and components and wide band sensor arrays, we propose to develop a new class of high performance compact, high resolution, wide band spectrometer-on-a-chip. The approach is closely coupled with recent progress in miniature spectrometer and sensor array to push the performance well beyond the current ...
STTR Phase I 2011 Department of DefenseAir Force -
Computational Prediction of Kinetic Rate Constants for Condensed Phases
SBC: Spectral Sciences, Inc. Topic: AF08BT19ABSTRACT: A core component of aerospace manufacturing is based on cutting-edge technological applications of material design. Chemical kinetics models are vital for interpreting experimental measurements and predicting the behavior of these complex systems. Modern computational chemistry software programs are invaluable for the accurate prediction of reaction rates for kinetics models, but thei ...
STTR Phase II 2011 Department of DefenseAir Force -
Decision Making under Uncertainty for Dynamic Spectrum Access
SBC: INFOBEYOND TECHNOLOGY, LLC Topic: AF13AT02ABSTRACT: Due to scarcity of spectrum, Dynamic Spectrum Access (DSA) becomes a needed technology to improve the utilization of electromagnetic spectrum for DoD satellite communication. However, current DSA approaches are developed for terrestrial communications without addressing the unique challenges for SATCOM environments such as error-prone spectrum sensing, high mobility, and large coverage. ...
STTR Phase I 2014 Department of DefenseAir Force -
Development of a clinical hemoglobin modulator
SBC: Phoenicia Biosciences, Inc. Topic: NHLBIDESCRIPTION provided by applicant The thalassemias and sickle cell disease are serious genetic blood diseases which are WHO designated as a growing global health burden The disorders decrease production or alter structure of the b chain of adult hemoglobin A and are characterized by anemia chronic organ damage and early mortality HbF is another type of normal hemoglobin which is suppres ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of an Innovative System for Cryodeposit Mitigation and Redmediation
SBC: Physical Sciences Inc. Topic: AF12BT10ABSTRACT: Physical Sciences Inc. (PSI) and the University of Tennessee Space Institute (UTSI) will develop an innovative system to measure and control the cryodeposit layer thickness that develops on cold (~20 K) surfaces in cryogenic radiometric calibration chambers. Currently removing the cryo-layer involves a lengthy process that warms the entire cryo-system to desorb the cryo-layer that incr ...
STTR Phase II 2014 Department of DefenseAir Force -
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis
SBC: OASIS PHARMACEUTICALS, LLC Topic: NIDDKDESCRIPTION provided by applicant Non alcoholic steatohepatitis NASH is characterized by fatty changes in the liver with inflammation and hepatocellular injury that in advanced stages leads to fibrosis and cirrhosis and high mortality rates NASH is frequently associated with other common metabolic abnormalities such as insulin resistance and visceral obesity Liver transplantation is curren ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health